Bio-Techne (TECH) Capital Expenditures (2009 - 2026)

Bio-Techne's Capital Expenditures history runs 18 years deep, the most recent figure standing at $9.1 million for Q1 2026.

• On a quarterly basis, Capital Expenditures fell 10.24% year-over-year to $9.1 million in Q1 2026; TTM through Mar 2026 was $25.3 million, a 42.72% decrease from a year earlier, with the FY2025 full-year figure at $31.0 million, down 50.69% from the prior year.
• Capital Expenditures grew to $9.1 million in Q1 2026 per TECH's latest filing, from $5.9 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $18.0 million in Q2 2024 and bottomed at $4.9 million in Q2 2025.
• The 5-year median for Capital Expenditures is $10.1 million (2025), against an average of $10.7 million.
• Across the five-year window, Capital Expenditures surged 143.31% in 2023 and tumbled 72.8% in 2025, its largest moves.
• Year by year, Capital Expenditures stood at $6.1 million in 2022, then surged by 143.31% to $14.9 million in 2023, then tumbled by 54.11% to $6.8 million in 2024, then slipped by 13.19% to $5.9 million in 2025, then surged by 53.45% to $9.1 million in 2026.
• Per Business Quant, the three latest TECH Capital Expenditures figures stand at $9.1 million (Q1 2026), $5.9 million (Q4 2025), and $5.4 million (Q3 2025).